Daniel B. Costa
Beth Israel Deaconess Medical Center(US)Harvard University(US)Instituto Federal de Educação Ciência e Tecnologia da Paraíba(BR)Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo(BR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer(2010)4,491 cited
- → Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer(2014)1,982 cited
- → Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK(2009)1,873 cited
- → Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints(2016)1,544 cited
- → Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study(2012)1,275 cited
- → Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis(2011)896 cited